Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy

Journal of Molecular Diagnostics

Volumn 12, Issue 5, 2010, Pages 653-663

  Elster, Eric A ^a,b,c   Hawksworth, Jason S ^a,b   Cheng, Orlena ^c   Leeser, David B ^d   Ring, Michael ^c   Tadaki, Douglas K ^a   Kleiner, David E ^e   Eberhardt III, John S ^f   Brown, Trevor S ^a   Mannon, Roslyn B ^c  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f DecisionQ Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD86 ANTIGEN; DACLIZUMAB; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MATRILYSIN; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BAYES THEOREM; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLOMERULOPATHY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; MONOTHERAPY; PROBABILITY; REAL TIME POLYMERASE CHAIN REACTION; TRANSPLANT GLOMERULOPATHY;

EID: 77956838077     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2010.090101     Document Type: Article

References (46)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004, 4:378-383
2. Racusen L: Chronic transplant glomerulopathy: need for further assessment. Clin J Am Soc Nephrol 2007, 2:1108-1109
3. Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AA, Schneeberger EE, Colvin RB: Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001, 12:574-582
4. Regele H, Bohmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S, Watschinger B, Kerjaschki D, Exner M: Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002, 13:2371-2380
5. Sis B, Campbell PM, Mueller T, Hunter C, Cockfield SM, Cruz J, Meng C, Wishart D, Solez K, Halloran PF: Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007, 7:1743-1752
6. Akalin E, Dinavahi R, Dikman S, de Boccardo G, Friedlander R, Schroppel B, Sehgal V, Bromberg JS, Heeger P, Murphy B: Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2007, 2:1261-1267
7. Al Aly Z, Yalamanchili P, Cortese C, Salinas-Madrigal L, Bastani B: C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding. Transpl Int 2005, 18:800-805
8. Gloor JM, Sethi S, Stegall MD, Park WD, Moore SB, DeGoey S, Griffin MD, Larson TS, Cosio FG: Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007, 7:2124-2132
9. Cosio FG, Gloor JM, Sethi S, Stegall MD: Transplant glomerulopathy. Am J Transplant 2008, 8:492-496
10. Akalin E, Dikman S, Murphy B, Bromberg JS, Hancock WW: Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am J Transplant 2003, 3:1116-1120
11. Hoffmann SC, Hale DA, Kleiner DE, Mannon RB, Kampen RL, Jacobson LM, Cendales LC, Swanson SJ, Becker BN, Kirk AD: Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005, 5:573-581
12. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou JC, Randhawa PS, C Rayner D, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y: The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55:713-723
13. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 2007, 7:518-526
14. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M: Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8:753-760
15. Hoffmann SC, Kampen RL, Amur S, Sharaf MA, Kleiner DE, Hunter K, John Swanson S, Hale DA, Mannon RB, Blair PJ, Kirk AD: Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002, 74:916-923
16. Hoffmann SC, Pearl JP, Blair PJ, Kirk AD: Immune profiling: molecular monitoring in renal transplantation. Front Biosci 2003, 8:e444-e462
17. Kohavi R: A study of cross-validation and bootstrap for accuracy estimation and model selection. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence Montreal, Canada, 1995
18. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD: Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005, 5:2464-2472
19. Jensen FV: An introduction to Bayesian networks. New York, Springer, 1996 pp 7-33
20. Grunkemeier GL, Payne N: Bayesian analysis: a new statistical paradigm for new technology. Ann Thorac Surg 2002, 74:1901-1908
21. Maskery SM, Hu H, Hooke J, Shriver CD, Liebman MN: A Bayesian derived network of breast pathology co-occurrence. J Biomed Inform 2008, 41:242-250
22. Montgomery SP, Swiecki CW, Shriver CD: The evaluation of casualties from Operation Iraqi Freedom on return to the continental United States from March to June 2003. J AmColl Surg 2005, 201:7-12; discussion 12-13
23. Diamond GA, Forrester JS: Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979, 300:1350-1358
24. Staniloff HM, Diamond GA, Freeman MR, Berman DS, Forrester JS: Simplified application of Bayesian analysis to multiple cardiologic tests. Clin Cardiol 1982, 5:630-636
25. Cornell LD, Smith RN, Colvin RB: Kidney transplantation: mechanisms of rejection and acceptance. Annu Rev Pathol 2008, 3:189-220
26. Kamoun M: Cellular and molecular parameters in human renal allograft rejection. Clin Biochem 2001, 34:29-34
27. Kouwenhoven EA, de Bruin RW, Heemann UW, Marquet RL, JN IJ: Transplantation of a single kidney per se does not lead to late graft dysfunction. Transpl Int 2001, 14:38-43
28. Rodder S, Scherer A, Raulf F, Berthier CC, Hertig A, Couzi L, Durrbach A, Rondeau E, Marti HP: Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. Am J Transplant 2009, 9:517-526
29. Mengel M, Bock O, Priess M, Haller H, Kreipe H, Gwinner W: Expression of pro- and antifibrotic genes in protocol biopsies from renal allografts with interstitial fibrosis and tubular atrophy. Clin Nephrol 2008, 69:408-416
30. Homs S, Mansour H, Desvaux D, Diet C, Hazan M, Buchler M, Lebranchu Y, Buob D, Badoual C, Matignon M, Audard V, Lang P, Grimbert P: Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant 2009, 9:1230-1236
31. Berthier C, Marti HP: Metzincins, including matrix metalloproteinases and meprin, in kidney transplantation. Swiss Med Wkly 2007, 137(Suppl 155):109S-114S
32. Palermo A, Mule G, Vadala A, Vaccaro F, Guarneri M, Arsena R, Briolotta C, Cerasola G, Cottone S: Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation. Nephrology (Carlton) 2008, 13:164-170
33. Meng L, Wu Z, Wang Y, Lassman C, Busuttil RW, Zhai Y, Kupiec-Weglinski JW: Differential impact of CD154 costimulation blockade on alloreactive effector and regulatory T cells in murine renal transplant recipients. Transplantation 2008, 85:1332-1338
34. Amirzargar M, Yavangi M, Basiri A, Moghadam SH, Khosravi F, Solgi G, Gholiaf M, Khoshkho F, Dadaras F, Mahmmodi M, Ansaripour B, Amirzargar A, Nikbin B: Genetic association of interleukin-4, interleukin-10, and transforming growth factor-beta gene polymorphism with allograft function in renal transplant patients. Transplant Proc 2007, 39:954-957
35. van den Boogaardt DE, van Miert PP, de Vaal YJ, de Fijter JW, Claas FH, Roelen DL: The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients. Transplantation 2006, 82:844-848
36. Kist-van Holthe JE, Gasser M, Womer K, Najafian N, Dong V, Samsonov DV, Geehan CS, Chandraker A, Sayegh MH, Waaga AM: Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int 2002, 62:627-631
37. Sun Q, Liu ZH, Ji S, Chen J, Tang Z, Zeng C, Zheng C, Li LS: Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation. Kidney Int 2006, 70:377-383
38. Fotheringham J, Angel CA, McKane W: Transplant glomerulopathy: morphology, associations, and mechanism. Nephron Clin Pract 2009, 113:c1-c7
39. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra O Jr: Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003, 349:125-138
40. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M: Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005, 353:2342-2351
41. Lachenbruch PA, Rosenberg AS, Bonvini E, Cavaille-Coll MW, Colvin RB: Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design. Am J Transplant 2004, 4:451-457
42. Allison M: Is personalized medicine finally arriving? Nature Biotechnol 2008, 26:509-517
43. Molitoris BA, Melnikov VY, Okusa MD, Himmelfarb J: Technology insight: biomarker development in acute kidney injury - what can we anticipate? Nat Clin Pract Nephrol 2008, 4:154-165
44. Burckart GJ, Amur S, Goodsaid FM, Lesko LJ, Frueh FW, Huang SM, Cavaille-Coll MW: Qualification of biomarkers for drug development in organ transplantation. Am J Transplant 2008, 8:267-270
45. Mannon RB, Kirk AD: Beyond histology: novel tools to diagnose allograft dysfunction. Clin J Am Soc Nephrol 2006, 1:358-366
46. Nankivell BJ, Chapman JR: Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006, 81:643-654